project id: TCGA-BLCA; case submitter id: TCGA-FT-A3EE; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.3; rna integrity number: 9.7; age at index: 80; days to birth: -29293; days to death: 99; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1931; year of death: 2011; age at diagnosis: 29293; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.5; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder neck; synchronous malignancy: No; tissue or organ of origin: Bladder neck; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 251; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-FT-A3EE-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 90.0;